Evidence map›Paper›PMID 26506050›Full record

Trial reportTranslational psychiatry2015

Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach.

F S Chen, R Kumsta, F Dvorak, G Domes, O S Yim, R P Ebstein, M Heinrichs

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. The Importance of Experimental Investigation of the CNS Oxytocin System.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. TheFrontiers in psychiatry · 2018
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

F S ChenDepartment of Psychology, Laboratory for Biological and Personality Psychology, University of Freiburg, Freiburg, Germany.
R KumstaDepartment of Genetic Psychology, Faculty of Psychology, Ruhr-University Bochum, Bochum, Germany.
F DvorakGraduate School of Decision Sciences, University of Konstanz, Konstanz, Germany.
G DomesDepartment of Psychology, Laboratory for Biological and Personality Psychology, University of Freiburg, Freiburg, Germany.
O S YimDepartment of Psychology, National University of Singapore, Singapore, Singapore.
R P EbsteinDepartment of Psychology, National University of Singapore, Singapore, Singapore.
M HeinrichsDepartment of Psychology, Laboratory for Biological and Personality Psychology, University of Freiburg, Freiburg, Germany.
National University of Singapore · SGUniversity of Freiburg · DERuhr University Bochum · DEUniversity of British Columbia · CAUniversity of Konstanz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intranasal administration of the neuropeptide oxytocin has been shown to influence a range of complex social cognitions and social behaviors, and it holds therapeutic potential for the treatment of mental disorders characterized by social functioning deficits such as autism, social phobia and borderline personality disorder. However, considerable variability exists in individual responses to oxytocin administration. Here, we undertook a study to investigate the role of genetic variation in sensitivity to exogenous oxytocin using a socioemotional task. In a randomized, double-blind, placebo-controlled experiment with a repeated-measures (crossover) design, we assessed the performance of 203 men on an emotion recognition task under oxytocin and placebo. We took a haplotype-based approach to investigate the association between oxytocin receptor gene variation and oxytocin sensitivity. We identified a six-marker haplotype block spanning the promoter region and intron 3 that was significantly associated with our measure of oxytocin sensitivity. Specifically, the TTCGGG haplotype comprising single-nucleotide polymorphisms rs237917-rs2268498-rs4564970-rs237897-rs2268495-rs53576 is associated with increased emotion recognition performance under oxytocin versus placebo, and the CCGAGA haplotype with the opposite pattern. These results on the genetic modulation of sensitivity to oxytocin document a significant source of individual differences with implications for personalized treatment approaches using oxytocin administration.

Indexed as

Social BehaviorAdultCross-Over StudiesDouble-Blind MethodEmotionsGenetic VariationHaplotypesHumansMaleOxytocinPharmacogeneticsPolymorphism, Single NucleotideReceptors, OxytocinRecognition, PsychologyTask Performance and AnalysisYoung AdultOxytocinReceptors, Oxytocin

Identifiers

PMID26506050
PMCPMC4930136
OpenAlexW2200924197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.